These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 39043513)

  • 1. A phase 3b, open-label, single-arm, multicenter, expanded-access study of the safety and clinical outcomes of StrataGraft® treatment in adults with deep partial-thickness thermal burns.
    Holmes Iv JH; Gibson ALF; Short T; Joe VC; Litt J; Carson J; Carter JE; Wibbenmeyer L; Hahn H; Smiell JM; Rutan R; Wu R; Shupp JW
    Burns; 2024 Nov; 50(8):2013-2022. PubMed ID: 39043513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 3, open-label, controlled, randomized, multicenter trial evaluating the efficacy and safety of StrataGraft® construct in patients with deep partial-thickness thermal burns.
    Gibson ALF; Holmes JH; Shupp JW; Smith D; Joe V; Carson J; Litt J; Kahn S; Short T; Cancio L; Rizzo J; Carter JE; Foster K; Lokuta MA; Comer AR; Smiell JM; Allen-Hoffmann BL
    Burns; 2021 Aug; 47(5):1024-1037. PubMed ID: 34099322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, prospective, randomized, controlled, multicenter, phase 1b study of StrataGraft skin tissue versus autografting in patients with deep partial-thickness thermal burns.
    Holmes JH; Schurr MJ; King BT; Foster K; Faucher LD; Lokuta MA; Comer AR; Rooney PJ; Barbeau KF; Mohoney ST; Gibson ALF; Lynn Allen-Hoffmann B
    Burns; 2019 Dec; 45(8):1749-1758. PubMed ID: 31416637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pooled safety analysis of STRATA2011 and STRATA2016 clinical trials evaluating the use of StrataGraft® in patients with deep partial-thickness thermal burns.
    Holmes Iv JH; Cancio LC; Carter JE; Faucher LD; Foster K; Hahn HD; King BT; Rutan R; Smiell JM; Wu R; Gibson ALF
    Burns; 2022 Dec; 48(8):1816-1824. PubMed ID: 35941023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The viable bioengineered allogeneic cellularized construct StrataGraft® synthesizes, deposits, and organizes human extracellular matrix proteins into tissue type-specific structures and secretes soluble factors associated with wound healing.
    Steiglitz BM; Maher RJ; Gratz KR; Schlosser S; Foster J; Pradhan-Bhatt S; Comer AR; Allen-Hoffmann BL
    Burns; 2024 Mar; 50(2):424-432. PubMed ID: 38087659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute.
    Schurr MJ; Foster KN; Centanni JM; Comer AR; Wicks A; Gibson AL; Thomas-Virnig CL; Schlosser SJ; Faucher LD; Lokuta MA; Allen-Hoffmann BL
    J Trauma; 2009 Mar; 66(3):866-73; discussion 873-4. PubMed ID: 19276766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on Inpatient Length of Stay in Adults with Deep Partial-Thickness Burns: Comparing the Bioengineered Allogeneic Cellularized Construct Expanded-Access Trial with National Burn Repository Data.
    Yu TC; Hahn H; Rutan R; Hu FS; Zheng Z
    Clinicoecon Outcomes Res; 2024; 16():647-656. PubMed ID: 39257454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).
    Rashaan ZM; Krijnen P; Kwa KAA; van der Vlies CH; Schipper IB; Breederveld RS
    Wound Repair Regen; 2019 May; 27(3):257-267. PubMed ID: 30675745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of Suprathel(®) in deep dermal burns: first results of a prospective study.
    Keck M; Selig HF; Lumenta DB; Kamolz LP; Mittlböck M; Frey M
    Burns; 2012 May; 38(3):388-95. PubMed ID: 22078803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of early debridement and conservative eschar removal followed by wound coverage with acellular dermal matrix in the treatment of children with deep burns].
    Liang Y; Shi W; Shao Y; Liu XZ; Gong HM; Cao GH; Gao C; Xin NJ; Song GD
    Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2024 Apr; 40(4):348-357. PubMed ID: 38664029
    [No Abstract]   [Full Text] [Related]  

  • 11. StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.
    Centanni JM; Straseski JA; Wicks A; Hank JA; Rasmussen CA; Lokuta MA; Schurr MJ; Foster KN; Faucher LD; Caruso DM; Comer AR; Allen-Hoffmann BL
    Ann Surg; 2011 Apr; 253(4):672-83. PubMed ID: 21475006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessment of safety and efficacy of intravenous delivery of autologous adipose-derived regenerative cells (ADRCs) in the treatment of severe thermal burns using a porcine model.
    Foubert P; Liu M; Anderson S; Rajoria R; Gutierrez D; Zafra D; Tenenhaus M; Fraser JK
    Burns; 2018 Sep; 44(6):1531-1542. PubMed ID: 29958745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical treatment for facial burns.
    Hoogewerf CJ; Hop MJ; Nieuwenhuis MK; Oen IM; Middelkoop E; Van Baar ME
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008058. PubMed ID: 32725896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.
    Rashaan ZM; Krijnen P; van den Akker-van Marle ME; van Baar ME; Vloemans AF; Dokter J; Tempelman FR; van der Vlies CH; Breederveld RS
    Trials; 2016 Mar; 17(1):122. PubMed ID: 26945575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Use of Dermal Substitute in Deep Burns of Functional/Mobile Anatomic Areas at Acute Phase After Early Excision and Subsequent Skin Autografting: Dermal Substitute Prevents Functional Limitations.
    Gurbuz K; Demir M; Das K
    J Burn Care Res; 2020 Sep; 41(5):1079-1083. PubMed ID: 32198511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preliminary effect observation on the application of micro-negative pressure in children with small-area deep partial-thickness burn].
    Zheng XP; Chen J; Chen TS; Jiang YN; Shen T; Xiao SC; Hu XY
    Zhonghua Shao Shang Za Zhi; 2019 Oct; 35(10):720-725. PubMed ID: 31658542
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of Burns Treated With Autologous Cultured Proliferating Epidermal Cells: A Prospective Randomized Multicenter Intrapatient Comparative Trial.
    Gardien KL; Marck RE; Bloemen MC; Waaijman T; Gibbs S; Ulrich MM; Middelkoop E;
    Cell Transplant; 2016; 25(3):437-48. PubMed ID: 26419871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of cell sheets containing allogeneic keratinocytes and fibroblasts for the treatment of partial-thickness burn wounds].
    Jiang YN; Wang YX; Zheng YJ; Hu XY; He F; Shi WJ; Wu Q; Xia ZF; Xiao SC
    Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):171-178. PubMed ID: 32241042
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effectiveness of scar split thickness skin graft combined with acellular allogeneic dermis in treatment of large deep II degree burn scar].
    Cui Z; Yang X; Shou J; Wang G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Dec; 28(12):1502-4. PubMed ID: 25826895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxepin cream is not effective in reducing itch in burn scar patients: A multicenter triple-blind randomized clinical crossover trial.
    Kwa KAA; Legemate CM; Pijpe A; Meij-de Vries A; Middelkoop E; van Baar ME; Breederveld RS; Nieuwenhuis MK
    Burns; 2020 Mar; 46(2):340-346. PubMed ID: 31839501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.